🇺🇸 FDA
Patent

US 10639350

Methods and pharmaceutical compositions for improving wound healing using CD24

granted A61KA61K38/177A61K38/1774

Quick answer

US patent 10639350 (Methods and pharmaceutical compositions for improving wound healing using CD24) held by The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center
Grant date
Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/177, A61K38/1774, A61K48/00, A61K9/0014